PHARMACOECONOMIC STUDY OF OLMESARTAN/LERCANIDIPINE AND OFENOPRIL/LERCANIDIPINE COMBINATIONS IN THE TREATMENT OF PATIENTS WITH ESSENTIAL HYPERTENSION

PHARMACOECONOMIC STUDY OF OLMESARTAN/LERCANIDIPINE AND OFENOPRIL/LERCANIDIPINE COMBINATIONS IN THE TREATMENT OF PATIENTS WITH ESSENTIAL HYPERTENSION

Objective. Pharmacoeconomic analysis of the use of combinations of antihypertensive drugs were olmesartan/lercanidipine and zofenopril/lercanidipine in patients with essential hypertension II-III stage.Materials and methods. The authors performed prospective randomized uncontrolled study. Were exami...

Full description

Bibliographic Details
Main Authors:	D. S. Kaskaeva, M. M. Petrova, O. V. Zimnitskaya
Format:	Article
Language:	Russian
Published:	IRBIS LLC 2017-03-01
Series:	Фармакоэкономика
Subjects:	pharmacoeconomic analysis сost-effectiveness analysis hypertension olmesartan zofenopril lercanidipine cer abc/ven-analysis.
Online Access:	https://www.pharmacoeconomics.ru/jour/article/view/162

Similar Items

Correction of Endothelial Dysfunction in Patients with Essential Hypertension when Using a Combination of Olmesartan/Lercanidipine and Zofenopril/Lercanidipine
by: O. V. Zimnitskaya, et al.
Published: (2016-11-01)

Clinical efficacy and cardioprotective capabilities of olmesartan and lercanidipine in the form of monotherapy and with their combined use in patients with arterial hypertension 1-2 degree
by: A. G Evdokimova, et al.
Published: (2017-03-01)

PHARMACOECONOMIC ANALYSIS OF OLMESARTAN THERAPY IN THE INDIVIDUAL–LEVEL MANAGEMENT OF ARTERIAL HYPERTENSION
by: S. G. Gorokhova, et al.
Published: (2012-08-01)

ASSESSMENT OF COGNITIVE FUNCTION IN PATIENTS WITH ESSENTIAL HYPERTENSION TREATED WITH LERCANIDIPINE
by: J. Tisaire-Sánchez, et al.
Published: (2011-04-01)

LERCANIDIPINE IN THE TREATMENT OF ARTERIAL HYPERTENSION
by: C. Beckey, et al.
Published: (2009-08-01)

Calcium antagonist lercanidipine in hypertension
by: G. A Baryshnikova, et al.
Published: (2014-03-01)

CALCIUM ANTAGONISTS IN ARTERIAL HYPERTENSION TREATMENT: SPECIFICS OF LERCANIDIPINE
by: I. O. Minushkina
Published: (2015-02-01)

CLINICAL EFFECTS AND RENOPROTECTIVE FACILITIES OF OLMESARTAN AND LERKANIDIPINEAS MONOTHERAPY AND WHEN COMBINED APPLICATION IN PATIENTS WITH ARTERIAL HYPERTENSION
by: A G Evdokimova, et al.
Published: (2016-03-01)

Pharmacoeconomic features of drug provision to the rheumatology department of the republican clinical hospital
by: L. N. Sheikhmambetova, et al.
Published: (2021-10-01)

Application of lercanidipine in the treatment of hypertension
by: G. G Shehyan, et al.
Published: (2014-06-01)

Lercanidipin chylous peritonitis
by: Hanene Gaied, et al.
Published: (2018-06-01)

THE EFFECTIVENESS OF LERCANIDIPINE IN REDUCING THE RISK OF ARTERIAL HYPERTENSION COMPLICATIONS
by: E. EL. Trisvetova
Published: (2015-09-01)

The Protective Effect of Lercanidipine on Indomethacin-Induced Gastric Ulcers in Rats
by: Durdu Altuner, et al.
Published: (2020-08-01)

OPTIMIZING THE TREATMENT OF PATIENTS WITH HYPERTENSION AND CORONARY HEART DISEASE WITH LERCANIDIPINE
by: E. L. Trisvetova
Published: (2015-09-01)

New Insights into the Nephroprotective Potential of Lercanidipine
by: Joanna Hajdys, et al.
Published: (2023-09-01)

LERCANIDIPINE, CALCIUM CHANNEL BLOCKER OF THE THIRD GENERATION: NEW POSSIBILITIES IN THE TREATMENT OF ARTERIAL HYPERTENSION
by: O. D. Ostroumova, et al.
Published: (2015-09-01)

Lercanidipine’s Antioxidative Effect Prevents Noise-Induced Hearing Loss
by: Zhaoqi Guo, et al.
Published: (2024-03-01)

Relationship between cardiac rhythm disorders, serum urotensin ІІ and angiotensin ІІ levels in patients with stage ii hypertension and carotid atherosclerosis in dynamics of treatment with candesartan and lercanidipine
by: O. V. Demidenko,, et al.
Published: (2016-10-01)

Lercanidipine/enalapril combination in the management of obesity-related hypertension
by: Grassi G
Published: (2016-04-01)

Fixed combinations in the management of hypertension: perspectives on lercanidipine – enalapril
by: Vivencio Barrios, et al.
Published: (2008-08-01)

The Effects of Eprosartan Mesylate and Lercanidipine on Reducing Microalbuminuria in Patients with Nephropathy due to Type 2 Diabetes
by: Botir T. Daminov, PhD, ScD, et al.
Published: (2013-06-01)

Pharmacoeconomic evaluation of drug supply for chemotherapy in small cell lung cancer
by: Yelena A. Lunyova
Published: (2023-07-01)

POSITIONS OF CALCIUM CHANNEL BLOCKER LERCANIDIPINE ACCORDING TO EVIDENCE BASED CARDIOLOGY
by: Yu. V. Lukina, et al.
Published: (2016-01-01)

Lercanidipine as a calcium antagonist of the third generation: a review of effectiveness in the hypertension treatment
by: V S Zadionchenko, et al.
Published: (2013-12-01)

Critical Analysis of Pharmaceuticals Inventory Management Using the ABC-VEN Matrix in Dessie Referral Hospital, Ethiopia
by: Mohammed SA, et al.
Published: (2020-09-01)

ABC END VEN ANALYSYS OF COSTS FOR MEDICINE SAND MEDICAL TREATMENT COSTS PATIENT
by: M. A. Shapovalova, et al.
Published: (2015-03-01)

Optimizing therapy for cardiovascular diseases: proven organ-protective and preventive effects of pitavastatin and lercanidipine: A review
by: Marina G. Bubnova
Published: (2022-07-01)

Determination of lercanidipine in human plasma by an improved UPLC–MS/MS method for a bioequivalence study
by: Darshan V. Chaudhary, et al.
Published: (2016-04-01)

ANTI-PROLIFERATIVE EFFECTIVENESS OF LERCANIDIPINE AND ITS MECHANISM OF ACTION (EXPERIMENTAL STUDY)
by: Jiunn-Ren Wu, et al.
Published: (2010-10-01)

HOSPITAL MEDICAL HELP IN THE NEUROLOGICAL PRACTICE AS A MEDICAL-AND-ECONOMICAL PROBLEM
by: L. R. Koretskaya, et al.
Published: (2016-02-01)

Development of three ecological spectroscopic methods for analysis of betrixaban either alone or in mixture with lercanidipine: greenness assessment
by: Amal A. El-Masry, et al.
Published: (2022-02-01)

Lercanidipine in hypertension
by: Claudio Borghi
Published: (2005-10-01)

Evaluation of Medication Planning with ABC-VEN Analysis at Indriati Solo Baru Hospital
by: Fiqri Zulpadly, et al.
Published: (2024-03-01)

Pharmacoeconomic analysis in various nosologies
by: A. A. Svistunov, et al.
Published: (2022-12-01)

Olmesartan/amlodipine: a review of its use in the management of hypertension
by: Kreutz R
Published: (2011-03-01)

Enteropatía por olmesartán
Published: (2017-12-01)

FIXED COMBINATION OF THE CALCIUM CHANNEL BLOCKER LERCANIDIPINE AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR ENALAPRIL: POSSIBILITY OF USAGE
by: O. D. Ostroumova, et al.
Published: (2015-09-01)

Lercanidipine in arterial hypertension
by: C. Borghi
Published: (1970-01-01)

ABC-, VEN- AND FREQUENCY ANALYSIS OF TREATMENT OF ATRIAL FIBRILLATION IN OUTCOME PATIENTS
by: A. N. Korobeynikova, et al.
Published: (2016-02-01)

PHARMACOECONOMIC STUDY OF LENVIMA (LENVATINIB) IN ADVANCED PROGRESSIVE RADIO IODINE REFRACTORY DIFFERENTIATED THYROID CANCER IN THE RUSSIAN FEDERATION
by: M. Yu. Frolov, et al.
Published: (2016-04-01)